Altidor M, Richardson C, Babu C, Baker H, et al. Use of short-course oral amenamevir (helicase-primase inhibitor) for the treatment of thymidine analogue-resistant herpes simplex lesions. Int J STD AIDS 2025 Nov 20:9564624251392819. doi: 10.1177/09564624251392819.
PMID: 41263820